oneplacenews
Source: Ars Technica
Summary
The FDA has approved a second species of carcass-eating fly for use in maggot therapy, which involves using live maggots to clean wounds. This development expands treatment options for patients with chronic and non-healing wounds.
Why It Matters
The approval of this second fly species enhances the effectiveness of maggot therapy, providing more options for healthcare professionals in treating difficult wounds. This method can significantly reduce infection rates and promote healing, ultimately improving patient outcomes and quality of life.
